ALBERT DAVID
Back to Balance Sheet
|
ALBERT DAVID Last 5 Year Total Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Liabilities | ₹637 Cr | ₹625 Cr | ₹604 Cr | ₹512 Cr | ₹475 Cr |
What is the latest Total Liabilities ratio of ALBERT DAVID ?
| Year | Total Liabilities |
|---|---|
| Mar2026 | ₹637 Cr |
| Mar2025 | ₹625 Cr |
| Mar2024 | ₹604 Cr |
| Mar2023 | ₹512 Cr |
| Mar2022 | ₹475 Cr |
How is Total Liabilities of ALBERT DAVID Trending?
| Years | Total Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹637 Cr | 1.93 | |
| Mar2025 | ₹625 Cr | 3.34 | |
| Mar2024 | ₹604 Cr | 17.98 | |
| Mar2023 | ₹512 Cr | 7.82 | |
| Mar2022 | ₹475 Cr | - | |
Compare Total Liabilities of peers of ALBERT DAVID
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ALBERT DAVID | ₹393.1 Cr | -0.1% | -2.4% | -23.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹470,270.0 Cr | -1.4% | 2.4% | 17.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹222,224.0 Cr | 12.2% | 23.1% | 21.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,325.0 Cr | 2.4% | 5.3% | 41.7% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | 1.7% | 0.7% | -3.8% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,876.6 Cr | 3% | -14.9% | -10.2% | Stock Analytics | |
ALBERT DAVID Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ALBERT DAVID | -0.1% |
-2.4% |
-23.7% |
| SENSEX | 2.2% |
0.9% |
-3.7% |
You may also like the below Video Courses